Shiitake, Lentinan & Eritadenine: Immune Defense and Cardiovascular Health
A research-led overview of Shiitake (Lentinula edodes) — covering lentinan's Dectin-1 / MAPK-NF-κB immune activation pathway, 12 years of clinical use as a cancer immunotherapy adjunct in China, eritadenine's dose-dependent LDL cholesterol reduction, and how shiitake polysaccharides support gut microbiome health.
Content Coming Soon
This resource is being prepared and will be available shortly.
Source Research Papers
Citations in APA 7 format. All studies were sourced from peer-reviewed journals via Google Scholar.
Ina, K., Kataoka, T., & Ando, T. (2013). The use of lentinan in treating gastric cancer. Anti-Cancer Agents in Medicinal Chemistry, 13(5), 681–688. https://doi.org/10.2174/1871520611313050002
Zhang, Y., Zhang, M., Jiang, Y., Li, X., He, Y., Zeng, P., Guo, Z., Chang, Y., Luo, H., & Liu, Y. (2018). Lentinan as an immunotherapeutic for treating lung cancer: A review of 12 years clinical studies in China. Journal of Cancer Research and Clinical Oncology, 144(11), 2177–2186. https://doi.org/10.1007/s00432-018-2684-x
Enman, J., Rova, U., & Berglund, K. A. (2007). Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes). Journal of Agricultural and Food Chemistry, 55(4), 1177–1180. https://doi.org/10.1021/jf062429e
Zhang, M., Zhang, Y., Zhang, L., & Tian, Q. (2019). Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China. Progress in Molecular Biology and Translational Science, 163, 297–328. https://doi.org/10.1016/bs.pmbts.2019.02.009
Chihara, G., Hamuro, J., Maeda, Y. Y., Shiio, T., Suga, T., Takasuka, N., & Sasaki, T. (1987). Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: An overview. Cancer Detection and Prevention Supplement, 1, 423–443.
Shop Related Spores
Laboratory-grade Psilocybe cubensis spore syringes for microscopy research.